996热re视频精品视频这里,国产又色又爽又高潮免费,精品自拍亚洲一区在线,久久久综合九色合综,国产精品亚洲综合一区在线观看

  • Theravance Biopharma, Mylan Submit NDA for Revefenacin americanpharmaceuticacreview
    November 14, 2017
    The NDA is supported by the companies' Phase 3 program for revefenacin, which consisted of two replicate pivotal Phase 3 efficacy studies and a 12-month, open-label, active comparator safety study.
  • AbbVie Submits NDA for Elagolix americanpharmaceuticacreview
    September 07, 2017
    AbbVie in cooperation with Neurocrine Biosciences has submitted a New Drug Application (NDA) to the U.S.

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194
+86 15021993094

PharmaSources Customer Service